Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Debt Ratio (2023 - 2025)

Xeris Biopharma Holdings' Debt Ratio history spans 3 years, with the latest figure at 0.57 for Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio fell 20.04% year-over-year to 0.57, compared with a TTM value of 0.57 through Dec 2025, down 20.04%, and an annual FY2025 reading of 0.57, down 20.04% over the prior year.
  • Debt Ratio for Q4 2025 was 0.57 at Xeris Biopharma Holdings, down from 0.59 in the prior quarter.
  • The five-year high for Debt Ratio was 0.73 in Q1 2025, with the low at 0.0 in Q2 2024.
  • Average Debt Ratio over 3 years is 0.36, with a median of 0.57 recorded in 2025.
  • Year-over-year, Debt Ratio tumbled 97.5% in 2024 and then skyrocketed 51494.53% in 2025.
  • Tracing XERS's Debt Ratio over 3 years: stood at 0.59 in 2023, then grew by 21.39% to 0.72 in 2024, then decreased by 20.04% to 0.57 in 2025.
  • Per Business Quant, the three most recent readings for XERS's Debt Ratio are 0.57 (Q4 2025), 0.59 (Q3 2025), and 0.65 (Q2 2025).